UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 29, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number ...

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 7, 2026 SELLAS Life Sciences Group, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33958 20-8099512 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Identification No.) 7 Times Square, Suite 2503 New York, ...

前行政总裁陈斌波酬金构成 - 前行政总裁陈斌波2019年度总酬金为318.9万元人民币[4] - 前行政总裁陈斌波2019年度薪金及其他福利为261.4万元人民币[4] - 前行政总裁陈斌波2019年度酌情性或绩效相关花红为54万元人民币[4] - 前行政总裁陈斌波2019年度退休福利计划供款为3.5万元人民币[4] 前行政总裁陈斌波任职与离任时间 - 前行政总裁陈斌波于2019年8月21日获委任[3] - 前行政总裁陈斌波于2022年5月31日退任执行董事及辞任行政总裁[3] 前行政总裁陈斌波其他薪酬事项 - 2019年度公司未向陈斌波支付任何加入诱因或离任补偿[4] 公司董事会主席信息 - 公司董事会主席为魏清莲[6]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CORMEDIX INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-34673 20-5894890 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 300 Connell Drive, Suite 4200 Berkeley Heights, New Jersey 07922 (Address of Principal Executive Offices) (Zip Code) Date of Report (Date of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ___________________________________________________ (Exact name of registrant as specified in its charter) ___________________________________________________ FORM 8-K ___________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026 ___________________________________________________ XENCOR, INC. (St ...

Exhibit 10.1 Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder identified by the mark "[***]". LOAN AND SECURITY AGREEMENT Dated as of January 7, 2026 among and any Person from time to time party hereto as a lender (in such capacity, with Avenue 2, a "Lender" and collectively, the "Lenders") LOAN AND SECURITY A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026 Personalis, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-38943 27-5411038 (State or Other Jurisdiction of Incorporation) 6600 Dumbarton Circle Fremont, California 94555 (Address of Principal Executive Offices) (Zip Code) (Commission File Number) (IRS ...

AXIL Brands, Inc. Reports Second Quarter Fiscal Year 2026 Financial Results LOS ANGELES, January 8, 2026 (GLOBE NEWSWIRE) – AXIL Brands, Inc. ("AXIL," "we," "us," "our," or the "Company") (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced financial and operational results for the second quarter ended November 30, 2025 (2Q26). Financial Highlights (Quarter Ended November 30, 2025) R ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to __________________ Commission File Number: 001-11038 ____________________ NORTHERN TECHNOLOGIES INTERNAT ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number: 001-41958 AXIL Brands, Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 47-4125218 | | -- ...